<DOC>
	<DOCNO>NCT00363766</DOCNO>
	<brief_summary>The primary objective estimate time progressive disease patient receive LY573636 two previous treatment metastatic non-small cell lung cancer . Patients receive intravenous infusion study drug every 21 day . CT-scans do first dose every treatment .</brief_summary>
	<brief_title>Study LY573636 Patients With Metastatic Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Diagnosis metastatic nonsmallcell lung cancer At least 18 year age Have receive 2 previous treatment regimen metastatic nonsmallcell lung cancer Serious preexist medical condition Previous cancer ( except skin cancer , exclude melanoma ) Have receive 3 previous treatment regimen metastatic non smallcell lung cancer Active treatment Coumadin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>